Purpose To determine the predictive value of markers for persistent subretinal fluid (SRF) absorption and the influence of subfoveal fluid on visual outcome after scleral buckle (SB) surgery for rhegmatogenous retinal detachment (RRD). Patients and methods This was a retrospective, observational study. We reviewed the medical records of 64 eyes of 64 patients who underwent SB surgery for macula-off RRD. Patients underwent clinical examination and spectral-domain optical coherence tomography before surgery, at 1 month and every 3 months postoperatively. The height and width of SRF bleb(s) were measured over time.
Introduction
After surgery for rhegmatogenous retinal detachment (RRD), the finding of persistent subretinal fluid (SRF) has been reported even when the retina appears fully attached on ophthalmoscopy and all retinal breaks are adequately sealed. This entity was probably first described by Machemer after resolution of experimental retinal detachment in owl monkeys. 1 The advent of optical coherence tomography (OCT) resulted in a number of reports of persistent SRF after RRD surgery. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Two patterns of residual SRF have been identified, confluent and bleb-like pockets of fluid and it has been reported that fluid can take more than 12 months to resolve. The presence of persistent SRF has been attributed to several possible causes without, however, conclusive evidence for either vitrectomy vs buckling surgery, the use of encircling vs segmental scleral explant, the use or omission of gas injection, completeness of SRF drainage, or cryotherapy. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] The incidence of persistent SRF varied widely among the published series, ranging from 9 to 94%. Furthermore, it remains unclear whether the visual outcome is affected: some authors have suggested that persistent submacular fluid does not influence visual outcome, 6, 8, 10 while others have disagreed. 3, 4, 13 These conflicting results may have been caused by short follow-up periods, small case numbers, or a lack of quantification of SRF.
In the current retrospective, observational study, patients with successfully repaired RRD after scleral buckle (SB) surgery underwent preoperative and postoperative spectral-domain OCT (SDOCT) to determine the predictive value of markers for persistent SRF absorption as well as the influence of subfoveal fluid on visual outcome. The incidence and the prognostic factors of the persistence of SRF after surgery were also evaluated.
Patients and methods
We reviewed the medical records of patients with primary RRD involving the fovea (macula-off), who were treated with SB surgery between January 2012 and January 2013. The study protocol was approved by the local ethics committee of the Sapienza University of Rome and adhered to the tenets of the Declaration of Helsinki Principles. From this cohort, patients who were evaluated for at least 3 months after surgery and who met the inclusion and exclusion criteria were finally selected.
Inclusion criteria were as follows: (1) successfully repaired primary macula-off RRD by a single, uncomplicated SB surgical procedure, (2) follow-up examination at 1 month and every 3 months thereafter, and (3) patients who underwent cataract surgery during the postoperative follow-up period, at least 6 months of follow-up after cataract surgery. Exclusion criteria were as follows: (1) macular pathologic features, such as agerelated macular degeneration, vitreomacular traction syndrome, macular hole, ERM, and macular oedema, (2) a history of amblyopia in the affected eye, (3) diabetes and a history of retinal vascular occlusion in the affected eye, (4) a history of intraocular surgery other than uncomplicated cataract surgery, (5) visually significant cataract that was not treated with cataract surgery during the follow-up, (6) traumatic RRD, (7) RD associated with vitreous haemorrhage or giant retinal tears, and (8) patients with postoperative extensive defects of the photoreceptor inner/outer segment junction hyperreflective line as evaluated by SDOCT.
All SB surgeries were performed by two experienced retinal surgeons (MG and RM) at the Umberto I University Hospital of Rome. After the positioning of an encircling silicone band, a circumferential silicone scleral explant was positioned to close the break(s). All eyes underwent external SRF drainage and cryotherapy application to the retinal break(s).
Before surgery, patients underwent a comprehensive ophthalmologic examination, including the measurement of Best-corrected visual acuity (BCVA), intraocular pressure, binocular indirect ophthalmoscopy, contact lens slit-lamp biomicroscopy, fundus photography, and OCT. Preoperative data collection included a complete medical and ophthalmic history, preoperative BCVA, characteristics of the RDs, lens status, and time from onset of the symptoms to surgery. The characteristics of the RDs and the presence of macular involvement were evaluated by binocular indirect ophthalmoscopy and slit-lamp biomicroscopy with the three-mirror Goldmann lens.
On each postoperative evaluation BCVA, complete ocular examination and OCT were performed. BCVA was measured using the standardized, 70-letter Early Treatment Diabetic Retinopathy Study chart (Chart 'R,' Precision Vision, La Salle, IL, USA) at 4 m distance. For statistical analysis, both preoperative and postoperative BCVA was analyzed on a logarithm of the minimal angle of resolution scale (logMAR). LogMAR values of 1.85 and 2.30 were assigned for counting fingers and hand motions vision at 2 feet, respectively.
SDOCT images were obtained, before and after surgery, with Spectralis OCT (Spectralis Family Acquisition Module, V 5.1.6.0; Heidelberg Engineering, Heidelberg, Germany), following a standardized protocol. Active eye-tracking (TruTrack, Heidelberg Engineering), and automatic follow-up scan (AutoRescan, Heidelberg Engineering) were used to enable point-topoint correspondence between consecutive followup scans.
Before surgery, a radial 30°, six lines scan protocol centred on the fovea were obtained for each eye with at least 16 frames averaged for each scan. The maximum height of the RD at the central fovea was defined as the distance between the outer surface of the detached neurosensory retina at the central fovea and the inner surface of the underlying retinal pigment epithelium. The height of the RD was measured using the digital caliper tool provided by the OCT software. The following preoperative retinal structural abnormalities were also evaluated: (1) cystoid changes in the inner nuclear layer, (2) cystoid or diffuse oedema in the outer nuclear layer, and (3) undulation of the photoreceptor layer.
After surgery, a raster horizontal 20°× 15°, 19 lines scan, with a reciprocal distance of 240 mm, and a radial 20°, six lines scan protocol centred on the fovea were obtained for each eye. More than 25 scans were averaged for each scan. All scans were evaluated for the presence of persistent SRF. Persistent SRF was classified into two patterns as follows: (1) diffuse submacular fluid that extended beyond the edge of the 6-mm scan and (2) bleblike, localized pockets of fluid. Patients in whom the OCT appearance was compatible with bleb-like SRF were divided into three groups according to the pockets' localization with respect to the central 1-mm diameter area: (1) subfoveal bleb of fluid, (2) extrafoveal bleb(s) of fluid, and (3) mixed subfoveal and extrafoveal blebs of fluid. To evaluate the serial morphologic changes that characterize SRF bleb regression, we selected one SRF bleb from each eye then measured its maximum width and height at time of initial stage and during the course of follow-up until its disappearance. Two independent observers took each manual measurement, and the average of both values was used for data analysis.
Statistical analysis
Statistical analysis was performed with the SPSS for windows (V 17.0, SPSS, IBM Software Group, Chicago, IL, USA). Normal distribution of data was analyzed by the Kolmogorov-Smirnov test. Longitudinal data were compared using the paired t-test or the Wilcoxon test, as appropriate. Intergroup differences were evaluated using the unpaired t-test or the Mann-Whitney rank-sum test, as appropriate. Categorical variables were compared using Fisher's exact test. Bivariate relationships were evaluated by the Spearman's coefficient or the Pearson's analysis, as appropriate. In the correlation analysis, the following preoperative parameters has been evaluated as prognostic factors for persistence of SRF at 1 month after surgery and BCVA outcome: age, gender, symptoms duration, BCVA, lens status, RD extent, cystoid changes in the inner nuclear layer, cystoid or diffuse oedema in the outer nuclear layer, and undulation of the photoreceptor layer.
The predictive value of markers for SRF absorption was evaluated using receiver-operating characteristic (ROC) curve analysis.
Data are reported as mean values ± SD. P-values of o0.05 were considered as statistically significant.
Results
Sixty-four eyes of 64 patients were included in this retrospective study. Forty-nine eyes completed the 6-month follow-up, 34 eyes completed the 9-month follow-up, and 27 eyes completed the 12-month follow-up to the time of results' evaluation. Patients' demographic and clinical characteristics at baseline are summarized in the Table 1 .
In 10 patients, it was not possible to obtain adequate preoperative OCT images of the macula as the RD was highly elevated. For the same cause, in 28 patients, it was not possible to measure the height of detachment. Persistent SRF at 1 month after surgery was observed in 40 eyes (62.5%). Six eyes (9.4%) had diffuse SRF, 4 eyes (6.3%) had subfoveal SRF bleb, 8 eyes (12.5%) had extrafoveal blebs and 22 eyes (34.4%) had mixed (subfoveal and extrafoveal) blebs. The cumulative survival curve of persistent SRF in all patients during follow-up was significantly different among SRF types (P = 0.03; Figure 1 ).
Demographics and preoperative clinical characteristics were compared between eyes with and without persistent SRF, no differences were found between groups in age, gender, symptoms duration, BCVA, lens status, RD OCT analysis of persistent SRF after RD surgery M Gharbiya et al extent, maximum height of the RD, and any of the preoperative retinal structural abnormalities as evaluated by SDOCT (P40.05; Table 1 ).
Of six eyes with confluent SRF at 1 month, SRF pattern turned from diffuse to bleb type in five cases during follow-up. In the remaining case it was no longer detectable at month 6 after surgery. Of 40 patients with persistent SRF at 1 month, we were able to verify the complete absorption of SRF with SDOCT during the follow-up period in 29 cases. SRF blebs were first recognizable at 1.7 ± 2.2 months postoperatively. SRF blebs were completely absorbed within 1 year after surgery in 26 eyes (90%) and within 18 months postoperatively in the remaining 3 eyes (10%). The average time for complete SRF bleb absorption was 7.8 ± 4.4 months postoperatively.
Mean SRF bleb height was 86 ± 30 μm at 1 month, 104 ± 42 μm at 3 months, 94 ± 39 μm at 6 months, 79 ± 33 μm at 9 months, and 100 ± 55 μm at 12 months. Mean SRF bleb width was 646 ± 329 μm at 1 month, 710 ± 495 μm at 3 months, 745 ± 483 μm at 6 months, 555 ± 246 μm at 9 months, and 538 ± 478 μm at 12 months. Compared with the initial stage, bleb width decreased significantly at all time points during the 12-month follow-up period (Po0.05), whereas significant bleb height decrease occurred from postoperative sixth month only (P o0.05). At 3 months, the percentage change of bleb height vs width was significantly different (P = 0.03; Figure 2 ). A representative case showing the natural course of residual SRF blebs after RRD surgery is given in Figure 3 .
Using the ROC curve analysis we found that the cutoff value of the bleb width-to-height ratio level for predicting bleb absorption at 6 months was 7, with 89% sensitivity and 83% specificity. The area under the ROC curve for bleb width-to-height ratio was 0.944 (P = 0.0001, 95% CI: 0.87-1).
Overall, compared with baseline, BCVA had improved significantly at all time points (Po0.0001). After surgery, BCVA was 0.35 ± 0.28 logMAR at 1 month, 0.23 ± 0.22 logMAR at 3 months, 0.20 ± 0.22 logMAR at 6 months, 0.16 ± 0.22 logMAR at 9 months, and 0.13 ± 0.17 logMAR at 12 months. BCVA outcome was found to be correlated with the maximum height of the RD before surgery (r = 0.46, P = 0.006 at 1 month; r = 0.59, Po0.0001 at 3 months; r = 0.64, Po0.0001 at 6 months; r = 0.58, P = 0.005 at 9 months; r = 0.58, P = 0.007 at 12 months) and with RD extent (r = 0.32, P = 0.01 at 3 months; r = 0.32, P = 0.02 at 6 months; r = 0.45, P = 0.005 at 9 months; r = 0.42, P = 0.02 at 12 months). We found little evidence of any association between BCVA outcome and each of age, gender, symptoms duration, preoperative BCVA, lens status, and the preoperative retinal structural abnormalities as evaluated by SDOCT (P40.05).
Subgroup analysis of cases with and without subfoveal fluid revealed that the greatest improvement in BCVA was seen within the first 3 months (Po0.001), although visual acuity continued to improve significantly until 12 months in both groups (Po0.05; Figure 4 ). There was no difference between groups in BCVA outcomes during the follow-up period (P40.05). In those eyes with persistent subfoveal fluid, the disappearance of SRF was associated with an improvement in BCVA, mean BCVA before and 3-month after SRF absorption was 0.26 ± 0.27 logMAR and 0.14 ± 0.18 logMAR, respectively (P = 0.003). We found no association between BCVA outcomes and subfoveal bleb height or width (P40.05).
Discussion
Residual 'pockets' of SRF are known to occur after SB surgery for RRD. In this study, we found that subfoveal located blebs may slow visual recovery, although final outcome was not influenced. We further demonstrated that a bleb width-to-height ratio 47 indicates a higher risk of SRF to persist beyond 6 months after surgery. The incidence of persistent SRF after SB for primary RRD varies widely, ranging from 9 to 94%, depending on the reported series. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] This variability among studies is probably related to differences in study design, baseline characteristics of patients and operating procedures. Our retrospective series demonstrated that 62.5% of eyes with macula-off RRD had persistent SRF on OCT at 1 month after surgery and this finding is consistent with most previous reports in this setting. Ricker et al 13 found persistent subfoveal fluid on OCT in up to 94% of patients with macula-off RRD at 1-month follow-up. This exceptionally high incidence may be ascribed to the operating procedure. Indeed, 76% of patients in Ricker's series underwent intraoperative SF6 gas injection that could have induced subfoveal fluid displacement.
Younger age, phakia, and longer standing inferior detachment all have been suggested as possible preoperative risk factors for persistent SRF after SB surgery without, however, conclusive evidence. 14 We found no association between persistence of SRF and these aforementioned factors. Clinical practice demonstrates that longstanding detachments with viscous SRF tend to show delayed fluid absorption. However, this relationship is difficult to prove, as data on the duration of RD are usually recorded retrospectively, relying on patient recollection as to the start of the symptoms, which may be markedly inaccurate.
In our results, the average time for complete SRF bleb absorption was 7.8 ± 4.4 months postoperatively. Compared with subfoveal blebs, diffuse SRF and mixed (subfoveal and extrafoveal) blebs tended to persist longer over time. It is not surprising that the rate of SRF absorption is related to the amount of persistent fluid.
Serial OCT analysis of residual SRF blebs showed that, compared with the initial stage, bleb width decreased significantly at all time points during the 12-month follow-up period, whereas significant bleb height decrease occurred from the sixth month only. These results are consistent with those reported in a recent retrospective study evaluating the temporal morphological changes of multiple SRF blebs. 15 During the natural course, the authors found a progressive bleb width decrease and height increase. This may result from the active reattachment of retinal pigment epithelium and photoreceptors at the margin of residual SRF bleb. 16 Experimental studies on animal models of RD showed a number of degenerative changes of the RPE, loss of apical villi, disappearance of phagosome from the cytoplasm, and misplacement of melanin granules and mitochondria. These morphologic changes imply that metabolic changes also occur in these cells in response to their loss of contact with photoreceptor outer segments. 17, 18 Furthermore, RPE proliferation with loss of surface polarity and Muller cell proliferation has also been described in the subretinal space. 17, 19 All these changes persisted, to some extent, in the reattached retina and have been described as having a 'patchwork' appearance. 20 This refers to the fact that the anatomical recovery across the RPE is not uniform, and some areas may lag behind others in forming a close photoreceptor-RPE apposition. Therefore, bleb-like pockets of persistent SRF may represent areas of residual RPE dysfunction (eg, decreased phagocytotic activity and/or active transport of ions). A further hypothesis, that does not exclude the previous, is related to the SRF composition. Indeed, biochemical and histological analysis have shown that large molecules such as proteins and GAG, as well as cells and cellular debris are concentrated particularly in longstanding SRF. 14, 21 These compounds cannot be removed through ion or water channels, resulting in an imbalance between the decreased capability of and the increased need for phagocytosis by RPE cells.
We observed a negative association between BCVA outcome and both the preoperative height and extent of RRD. These findings are consistent with those of experimental studies on animal model that showed more progressive outer retinal damage with greater height of the retinal detachment. 1, 17, 22 Accordingly, clinical studies, evaluating the morphology of the detached macula in primary RRD by SDOCT, showed that higher retinal detachment at the fovea was correlated with dropout of foveal photoreceptor IS/OS layer and worse postoperative VA. 23, 24 Although we did not find any significant difference in VA outcome between eyes with persistent subfoveal fluid and those without subfoveal fluid, subgroup analysis revealed that in those eyes with residual subfoveal fluid, the disappearance of fluid was associated with an improvement in visual acuity. Our results, along with those of Benson et al 8 and Seo et al, 10 suggest that there is an association of delayed visual recovery in patients with macula-off RRD and residual SRF; however, the final visual outcome does not seem to be affected. In addition, we found no association between height or width of subfoveal SRF and VA outcome. Mean height of subfoveal SRF in our series was relatively stable at 90 μm until SRF disappeared. Similar to our results, Seo et al 10 observed that persistent SRF of~100 μm height within 12 months may slow visual recovery but does not cause VA loss after SB surgery for macula-off RRD. However, BCVA, which was used in our study as well as in previous reports, might not be enough to evaluate the detailed visual function. Indeed, Okamoto et al, 25 in a recent study evaluating metamorphopsia after RRD surgery, found that metamorphopsia was more severe in eyes with persistent submacular fluid. Further studies using other measurement of visual function such as microperimetry and contrast sensitivity can better evaluate the actual clinical implications of persistent SRF in this setting. The limitations of the present study are its retrospective design and the small sample size.
In this retrospective series, our results showed that 62.5% of eyes with macula-off RRD had persistent SRF on OCT at 1 month after SB surgery. Visual improvement may occur with late resolution of residual subfoveal fluid.
Serial morphological analysis of residual subfoveal bleb showed no relation between VA outcomes and the bleb size. We further demonstrated that a bleb width-to-height ratio 47 indicates a higher risk of SRF to persist beyond 6 months after surgery. This clinical information may have valuable implications for the patient's prognosis and may allow clinicians to better address patients' expectations of visual recovery after surgery.
Summary
What was known before K Persistent subretinal fluid has been reported after retinal detachment surgery, however, it remains unclear whether the visual acuity outcome is affected.
K Only one SDOCT study analysed the serial changes of SRF bleb size during the natural course. A progressive bleb width decrease and height increase was observed.
What this study adds K There was no difference in visual acuity outcomes between cases with persistent subfoval fluid and those without fluid. However, the disappearance of residual subfoveal fluid was associated with an improvement of visual acuity.
K A bleb width-to-height ratio 47 indicates a higher risk of SRF to persist beyond 6 months after surgery.
K Our study showed that compared with the initial stage, bleb width decreased significantly at all time points during the 12-month follow-up period, whereas significant bleb height decrease occurred from postoperative sixth month only. This suggests that SRF absorption is mediated by the photoreceptor-EPR complex active metabolism at the margin of residual SRF bleb.
